Feinberg David T

Director · EW, HUM

As of 2026-09-16, Feinberg David T has 11 Form 4 transactions on record across 2 companies — 5 in the trailing 12 months.

Everything this person has disclosed to the SEC on Form 4 — across every company they file for — reconstructed from the public record. A filing history, not a tip sheet.

Reconstructed holdings

Direct: $1.3MIndirect: $0$1.3Mas of 2026-09-16
  • Direct $1.3M
  • Indirect $0
EWdirect9,087 sh$811K
HUMdirect1,207 sh$464K

Reconstructed from this person's own Form 4 filings — the total each filing reported owning afterward, priced at the close on the as-of date shown. A filed position can lag the real one.

Direct and indirect holdings (e.g. through a trust or fund) are tagged separately, as filed.

Trades by company

HUM · 9 trades
2026-01-02: Award / grant, 766 sh ($0)2025-12-31: Award / grant, 70 sh ($18K)2025-12-31: Award / grant, 29 sh ($8K)2025-09-30: Award / grant, 69 sh ($18K)2025-06-30: Award / grant, 76 sh ($18K)2025-03-31: Award / grant, 66 sh ($17K)2025-01-02: Award / grant, 783 sh ($0)2024-12-31: Award / grant, 131 sh ($33K)2024-12-31: Award / grant, 14 sh ($4K)
EW · 2 trades
2026-05-08: Award / grant, 3,251 sh ($0)2025-05-09: Award / grant, 3,528 sh ($0)

Filing ledger

DateCompanyActionShares @ priceValueOwnership ΔOwned afterFiling
11 award / exercise / gift records — not counted as purchases
DateCompanyActionSharesOwned afterFiling
2026-05-08EWAward / grant3,2519,087Form 4
2026-01-02HUMAward / grant7661,207Form 4
2025-12-31HUMAward / grant70708Form 4
2025-12-31HUMAward / grant2946Form 4
2025-09-30HUMAward / grant69638Form 4
2025-06-30HUMAward / grant76569Form 4
2025-05-09EWAward / grant3,5285,836Form 4
2025-03-31HUMAward / grant66493Form 4
2025-01-02HUMAward / grant7831,593Form 4
2024-12-31HUMAward / grant131427Form 4
2024-12-31HUMAward / grant1417Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.